72985-24-1

Upstream product

• 675148-96-6 methyl 5-formyl-2-methylbenzoate 
• 105650-34-8 5-formyl-2-methylbenzoic acid 
• 67-56-1 methanol 
• 72985-21-8 5-(hydroxymethyl)-2-methylbenzoic acid 
• 75-75-2 methanesulfonic acid 
• 68120-35-4 (3-bromo-4-methyl-phenyl)-methanol 
• 104-87-0 4-methyl-benzaldehyde 
• 36276-24-1 3-bromo-4-methyl-benzaldehyde 

Downstream Products

• 72985-25-2 Methyl-5-(methoxymethyl)-2-methylbenzoate 
• 675148-96-6 methyl 5-formyl-2-methylbenzoate 
• 105650-34-8 5-formyl-2-methylbenzoic acid 
• 72985-28-5 3,5'-Bis(methoxymethyl)-2'-methyldeoxybenzoin trimethylene dithioketal 
• 72985-00-3 3,5'-Bis(brommethyl)-2'-methyldeoxybenzoin trimethylene dithioketal 
• 72984-98-6 3,5'-Bis(methoxymethyl)-2'-methyldeoxybenzoin 
• 72984-99-7 3,5'-Bis(bromomethyl)-2'-methyldeoxybenzoin 
• 72985-26-3 5-(Methoxymethyl)-2-methylbenzyl alcohol 
• 72985-27-4 5-(Methoxymethyl)-2-methylbenzyl bromide 

Relevant academic research and scientific papers

PHENYL mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

OLEFIN SUBSTITUTED OXINDOLES HAVING AMPK ACTIVITY

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.